Kiora Pharmaceuticals, Inc.
General ticker "KPRX" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $12.5M (TTM average)
Kiora Pharmaceuticals, Inc. does not follow the US Stock Market performance with the rate: -18.9%.
Estimated limits based on current volatility of 4.6%: low 1.95$, high 2.13$
Factors to consider:
- Total employees count: 12 (0.0%) as of 2023
- Top business risk factors: Operating losses, Need for additional capital, Dependence on key products, Distribution risks, Market competition
- Current price 11.1% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [2.42$, 4.99$]
- 2025-12-31 to 2026-12-31 estimated range: [2.39$, 4.89$]
Short-term KPRX quotes
Long-term KPRX plot with estimates
Financial data
| YTD | 2024-12-31 |
|---|---|
| Operating Revenue | $16.00MM |
| Operating Expenses | $11.49MM |
| Operating Income | $4.51MM |
| Non-Operating Income | $1.15MM |
| Interest Expense | $0.02MM |
| R&D Expense | $4.90MM |
| Income(Loss) | $5.66MM |
| Taxes | $2.07MM |
| Profit(Loss)* | $3.59MM |
| Stockholders Equity | $25.76MM |
| Assets | $36.48MM |
| Operating Cash Flow | $8.56MM |
| Capital expenditure | $0.01MM |
| Investing Cash Flow | $-22.66MM |
| Financing Cash Flow | $15.50MM |
| Earnings Per Share** | $0.93 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.